Trial Profile
A trial to evaluate the effectiveness of simeprevir-based triple therapy for patients with prior telaprevir treatment failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Peginterferon alfa (Primary) ; Ribavirin (Primary) ; Simeprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 02 Jun 2016 New trial record